X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

"If Washington isn’t careful, we might leave innovation behind"

By Robert Zirkelbach  |    June 24, 2019
“Trying to make medications more affordable is important, but if Washington isn’t careful, we might leave innovation behind.” This is the message we heard from Amy, a Voters for Cures advocate...   Read More

Giving patients a voice: PhRMA launches Voters for Cures to support the next generation of treatments and cures

By Robert Zirkelbach  |    April 25, 2019
When we launched the GOBOLDLY campaign two years ago, we set out to spotlight the new era of medicine and the tremendous opportunity that exists to tackle our most complex and devastating health...   Read More

New report shows nearly 300 cell and gene therapies in development

By Andrew Powaleny  |    December 6, 2018
Fifty years ago, the idea of altering a gene to treat or even cure a disease was considered science fiction. Today, cell and gene therapy are transforming treatment options for some patients and...   Read More

New report shows more than 300 skin disease medicines in development

By Andrew Powaleny  |    September 25, 2018
More than 100 million Americans – one third of the U.S. population – suffer from skin conditions.   Read More

Event next week: Supporting the next generation of lifesaving medicines

By Andrew Powaleny  |    July 12, 2018
The remarkable scientific advancements in recent history are due, in part, to thoughtful public policies that promote innovation and discovery. These policies support the tireless efforts of more...   Read More

Aspen Spotlight Health: Discussing the forefront of innovation

By Katie Koziara  |    June 21, 2018
For the second year in a row, PhRMA is proud to participate in Aspen’s Spotlight Health Conference. As the opening session of Aspen Ideas Festival, Spotlight Health welcomes over 1,500 experts and...   Read More

Event tomorrow: Improving patient access to lifesaving medicines

By Andrew Powaleny  |    May 22, 2018
Despite the current unprecedented pace of biopharmaceutical innovation, patients continue to face rising out-of-pocket costs and other barriers to care. Tomorrow, in partnership with The Atlantic,...   Read More

ICYMI –Report highlights increasing prevalence for Alzheimer’s disease

By Andrew Powaleny  |    December 11, 2017
The number of Americans affected by Alzheimer’s disease (AD) continues to rise according to a new report.1 Researchers found that approximately 6.08 million Americans had Alzheimer’s or mild...   Read More

New report and event examine the new era of vaccines

By Andrew Powaleny  |    November 9, 2017
Today, leading minds will come together for an in-depth conversation centered on vaccines – their critical role in warding off disease, the innovative science powering breakthroughs in their...   Read More

A new era in cancer

By Andrew Powaleny  |    November 1, 2017
The last few years have seen unparalleled progress in cancer care, with breakthrough research driving major advances in diagnosis and treatment. Next week, on Wednesday, November 8, leading minds...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates